Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 6, 2011, Pages 243-247

  Tuček, Lubos ^a   Petera, Jiri ^a   Sirák, Igor ^a   Vošmik, Milan ^a   Doležalová, Helena ^a   Brokešová, Simona ^a   Hodek, Miroslav ^a   Kašaová, Linda ^a   Paluska, Petr ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

High dose rate brachytherapy; Oral cancer

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; JAW OSTEONECROSIS; MALE; RADIATION DOSE FRACTIONATION; RADIATION SHIELD; RETROSPECTIVE STUDY; SALVAGE THERAPY; SOFT TISSUE DISEASE; SQUAMOUS CELL CARCINOMA; TISSUE NECROSIS; TONGUE CANCER; TUBE;

EID: 82755182816     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.07.001     Document Type: Article

References (21)

1. Guedea F., Ventura M., Polo A., et al. Patterns of care for brachytherapy in Europe (PC BE) in Spain and Poland: comparative results. Rep Pract Oncol Radiother 2007, 12:39-45.
2. Lebioda A., Makarewicz R., Rembielak A., Bialas B., Kabacinska R. Estimation of the α/β ratio for lower lip cancer treated with interstitial HDR brachytherapy. Rep Pract Oncol Radiother 2007, 12:207-2010.
3. Strnad V. Treatment of oral cavity and oropharyngeal cancer. Indications, technical aspects and results of interstitial brachytherapy. Strahlenther Onkol 2004, 180:710-717.
4. Whitehurst J.O., Droulias C.A. Surgical treatment of squamous cell carcinoma of the oral tongue: factors influencing survival. Arch Otolaryngol 1977, 103:212-215.
5. Spio R., Strong E.W. Epidermoid carcinoma of the mobile tongue. Treatment by partial glossectomy only. Am J Surg 1971, 122:707-710.
6. Mazeron J.J., Crook J.M., Benck V., et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990, 19:1369-1376.
7. Umeda M., Komatsubara H., Nishimatsu N., Yokoo S., Shibuya Y., Komori T. High-dose rate interstitial brachytherapy for the stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 90:667-670.
8. Lau H.Y., Hay J.H., Flores A.D., Therfall W.J. Seven fractions of twice daily high-dose rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996, 39:15-18.
9. Inoue T., Inoue T., Yoshida K., et al. Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys 2001, 51:171-175.
10. Yamazaki H., Inoue T., Yoshida K., et al. Brachytherapy for early tongue cancer: low dose rate to high dose rate. J Radiat Res 2003, 44:37-40.
11. Nag S., Cano E.R., Demanses D.J., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 2001, 50:1190-1198.
12. Guinot J.L., Santos M., Tortajada M.I., et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy 2010, 9:227-234.
13. Benk V., Mazeron J.J., Grimad L., et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990, 18:339-347.
14. Shibuya H., Hoshina M., Takeda M., Matsumoto S.A., Suzuku S., Okada N. Brachytherapy for stage I & II oral tongue cancer. An analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys 1990, 26:51-58.
15. Fujita M., Hirokawa Y., Kashiwado K., et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys 1999, 44:767-775.
16. Vandenbrouck C., Sancho-Garnier H., Chassagne D., Saravane D., Cachin Y., Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of randomized clinical trial. Cancer 1980, 46:386-390.
17. Mazeron J.J., Crook J.M., Marinello G., Walop W., Pierquin B. Prognostic factors of local outcome for T1 T2 carcinomas of oral tongue treated by Iridium 192 implantation. Int J Radiat Oncol Biol Phys 1990, 19:281-285.
18. Pernot M., Malissard L., Aletti P., Hoffstetter S., Forcard J.J., Bey P. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol 1992, 23:223-228.
19. Nakagawa T., Shibuya H., Yoshimura R., et al. Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radioth Oncol 2003, 68:129-135.
20. Chakrabarti B., Chorai S., Basu B., et al. Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy: an institutional experience of 42 cases in India. Brachytherapy 2010, 9:254-259.
21. Watanabe H., Mogushi K., Miura M., et al. Prediction of lymphatic metastasis based on gene expression profile analysis after BT for early stage oral tongue carcinoma. Radiother Oncol 2008, 87:237-242.